Journal of Clinical Medicine (Nov 2020)

Why Methodology Is Important: Coffee as a Candidate Treatment for COVID-19?

  • Yaniss Belaroussi,
  • Paul Roblot,
  • Nathan Peiffer-Smadja,
  • Thomas Delaye,
  • Simone Mathoulin-Pelissier,
  • Joffrey Lemeux,
  • Gwenaël Le Moal,
  • Eric Caumes,
  • France Roblot,
  • Alexandre Bleibtreu

DOI
https://doi.org/10.3390/jcm9113691
Journal volume & issue
Vol. 9, no. 11
p. 3691

Abstract

Read online

Background: During this pandemic situation, some studies have led to hasty conclusions about Corona Virus Disease-19 (COVID-19) treatment, due to a lack of methodology. This pedagogic study aimed to highlight potential biases in research on COVID-19 treatment. Methods: We evaluate the effect of coffee’s active part, 1,3,7-trimethylxanthine (TMX) on patients with COVID-19. A cohort of 93 patients, with a diagnosis of COVID-19 is analyzed. Results: TMX group and control group included, respectively, 26 and 67 patients. In the TMX group, patients had a median length of stay in hospital of 5.5 days shorter than in the control group (9.5 vs. 15 days, p p = 0.002). Conclusions: Multiple biases prevents us from concluding to an effect of coffee on COVID-19. Despite an important social pressure during this crisis, methodology and conscientiousness are the best way to avoid hasty conclusions that can be deleterious for patients. Identifier: NCT04395742.

Keywords